{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:29:37Z","timestamp":1790828977590,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Major Special Projects Funding Program","award":["2018ZX09737-011"],"award-info":[{"award-number":["2018ZX09737-011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Enterovirus A-71 (EV71) is a global, highly contagkkious pathogen responsible for severe cases of hand-food-mouth-disease (HFMD). The use of vaccines eliciting cross neutralizing antibodies (NTAbs) against the different circulating EV71 sub-genotypes is important for preventing HFMD outbreaks. Here, we tested the cross-neutralizing activities induced by EV71 genotype\/sub-genotype A, B0-B4, C1, C2, C4, and C5 viruses using rats. Differences were noted in the cross-neutralization of the 10 sub-genotypes tested but there were generally good levels of cross-neutralization except against genotype A virus, against which neutralization antibody titres (NTAb) where the lowest with NTAbs being the highest against sub-genotype B4. Moreover, NTAb responses induced by C4, B4, C1, and C2 viruses were homogenous, with values of maximum\/minimum NTAb ratios (MAX\/MIN) against all B and C viruses ranging between 4.0 and 6.0, whereas MAX\/MIN values against B3 and A viruses were highly variable, 48.0 and 256.0, respectively. We then dissected the cross-neutralizing ability of sera from infants and children and rats immunized with C4 EV71 vaccines. Cross-neutralizing titers against the 10 sub-genotypes were good in both vaccinated infants and children and rats with the MAX\/MIN ranging from 1.8\u20133.4 and 5.1\u20137.1, respectively, which were similar to those found in naturally infected patients (2.8). Therefore, we conclude that C4 EV71 vaccines can provide global protection to infants and children against HFMD caused by different sub-genotypes.<\/jats:p>","DOI":"10.3390\/v13050720","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T21:25:10Z","timestamp":1619040310000},"page":"720","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy"],"prefix":"10.3390","volume":"13","author":[{"given":"Pei","family":"Liu","sequence":"first","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Yuan","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bopei","family":"Cui","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Huo","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianlian","family":"Bian","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[{"name":"Minhai Biotechnology CO., LTD, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfei","family":"Wang","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhi","family":"Xu","sequence":"additional","affiliation":[{"name":"Minhai Biotechnology CO., LTD, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Tedcastle","sequence":"additional","affiliation":[{"name":"Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunying","family":"Mao","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5326-7081","authenticated-orcid":false,"given":"Javier","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglun","family":"Liang","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1080\/21645515.2015.1049780","article-title":"Is a multivalent hand, foot, and mouth disease vaccine feasible?","volume":"11","author":"Klein","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00705-010-0722-0","article-title":"Emergence of enterovirus 71 \u201cdouble-recombinant\u201d strains belonging to a novel genotype D originating from southern China: First evidence for combination of intratypic and intertypic recombination events in EV71","volume":"155","author":"Yip","year":"2010","journal-title":"Arch. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bessaud, M., Razafindratsimandresy, R., Nougair\u00e8de, A., Joffret, M.L., Deshpande, J.M., Dubot-P\u00e9r\u00e8s, A., H\u00e9raud, J.M., de Lamballerie, X., Delpeyroux, F., and Bailly, J.L. (2014). Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090624"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cid\/ciu852","article-title":"Review of enterovirus 71 vaccines","volume":"60","author":"Chong","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","article-title":"An apparently new enterovirus isolated from patients with disease of the central nervous system","volume":"129","author":"Schmidt","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1076","DOI":"10.1016\/j.ijid.2010.07.006","article-title":"The largest outbreak of hand; foot and mouth disease in Singapore in 2008: The role of enterovirus 71 and coxsackievirus A strains","volume":"14","author":"Wu","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ang, L.W., Phoon, M.C., Wu, Y., Cutter, J., James, L., and Chow, V.T. (2011). The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore. BMC Infect. Dis., 11.","DOI":"10.1186\/1471-2334-11-270"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e01112-13","DOI":"10.1128\/genomeA.01112-13","article-title":"Complete genome sequence of a human enterovirus 71 strain isolated in wuhan, china, in 2010","volume":"1","author":"Yang","year":"2013","journal-title":"Genome Announc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pedneo.2013.07.007","article-title":"Epidemiology of enterovirus 71 infections in Taiwan","volume":"55","author":"Chia","year":"2014","journal-title":"Pediatr. Neonatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3201\/eid1311.070632","article-title":"Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005","volume":"13","author":"Thao","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1128\/JCM.43.12.6171-6175.2005","article-title":"Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003","volume":"43","author":"Mizuta","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3345\/kjp.2010.53.5.616","article-title":"Enterovirus 71 infection: An experience in Korea, 2009","volume":"53","author":"Kim","year":"2010","journal-title":"Korean J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM199909233411301","article-title":"An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group","volume":"341","author":"Ho","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_16","unstructured":"(2018, February 26). National Health Commission of the People\u2019s Republic of China, Available online: http:\/\/www.nhc.gov.cn\/jkj\/s3578\/201802\/de926bdb046749abb7b0a8e23d929104.shtml."},{"key":"ref_17","first-page":"121","article-title":"Background and key-point for WHO issued recommendations for the quality, safety and efficacy of enterovirus 71 vaccines (inactivated)","volume":"34","author":"Mao","year":"2021","journal-title":"Chin. J. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/14760584.2016.1138862","article-title":"EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)","volume":"15","author":"Mao","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_22","unstructured":"National Health Commission of the People\u2019s Republic of China (2021, March 12). National Notifiable Infectious Diseases, Available online: http:\/\/www.nhc.gov.cn\/jkj\/s3578\/202103\/f1a448b7df7d4760976fea6d55834966.shtml."},{"key":"ref_23","first-page":"426","article-title":"Molecular epidemiology and evolution of human enterovirus 71 and hand, foot and mouth disease","volume":"37","author":"Zhifang","year":"2015","journal-title":"Hereditas"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1128\/JCM.00507-09","article-title":"Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008","volume":"47","author":"Koopmans","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1128\/JVI.73.12.9969-9975.1999","article-title":"Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998","volume":"73","author":"Brown","year":"1999","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11262-009-0440-4","article-title":"Detection of non-polio enteroviruses in Hungary 2000-2008 and molecular epidemiology of enterovirus 71, coxsackievirus A16, and echovirus 30","volume":"40","author":"Kapusinszky","year":"2010","journal-title":"Virus Genes"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/01.inf.0000227959.89339.c3","article-title":"Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003","volume":"25","author":"Hosoya","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1442-200x.2004.01868.x","article-title":"Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region","volume":"46","author":"Shimizu","year":"2004","journal-title":"Pediatr. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00705-005-0684-9","article-title":"Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community","volume":"151","author":"Sanders","year":"2006","journal-title":"Arch. Virol."},{"key":"ref_30","first-page":"451","article-title":"Comparative genetic analysis of VP4, VP1 and 3D gene regions of enterovirus 71 and coxsackievirus A16 circulating in Malaysia between 1997\u20132008","volume":"29","author":"Chan","year":"2012","journal-title":"Trop. Biomed."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhu, J., Luo, Z., Wang, J., Xu, Z., Chen, H., Fan, D., Gao, N., Ping, G., Zhou, Z., and Zhang, Y. (2013). Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056318"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jcv.2009.02.002","article-title":"An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China","volume":"44","author":"Zhang","year":"2009","journal-title":"J. Clin. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3201\/eid0904.020395","article-title":"Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: Comparative analysis of the VP1 and VP4 genes","volume":"9","author":"Cardosa","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.vaccine.2012.10.032","article-title":"Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity","volume":"31","author":"Chen","year":"2013","journal-title":"Vaccine"},{"key":"ref_36","first-page":"725","article-title":"Screening and preparation of candidate standard strain for determination of neutralizing antibody against enterovirus 71","volume":"25","author":"Mao","year":"2012","journal-title":"Chin. J. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.vaccine.2009.03.060","article-title":"Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007","volume":"27","author":"Mizuta","year":"2009","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1099\/vir.0.019695-0","article-title":"Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses","volume":"91","author":"Lemey","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Chia, M.Y., Chung, W.Y., Chiang, P.S., Chien, Y.S., Ho, M.S., and Lee, M.S. (2014). Monitoring antigenic variations of enterovirus 71: Implications for virus surveillance and vaccine development. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0003044"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.1955.02960140001001","article-title":"Considerations in the preparation and use of poliomyelitis virus vaccine","volume":"158","author":"Salk","year":"1984","journal-title":"JAMA"},{"key":"ref_41","first-page":"23","article-title":"Immunization with live attenuated poliovirus vaccine","volume":"101","author":"Krugman","year":"1961","journal-title":"Am. J. Dis. Child."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jama.1994.03510410040030","article-title":"Protection against hepatitis A by an inactivated vaccine","volume":"271","author":"Innis","year":"1994","journal-title":"JAMA"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Chou, A.H., Liu, C.C., Chang, J.Y., Jiang, R., Hsieh, Y.C., Tsao, A., Wu, C.L., Huang, J.L., Fung, C.P., and Hsieh, S.M. (2013). Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079783"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mao, Q., Cheng, T., Zhu, F., Li, J., Wang, Y., Li, Y., Gao, F., Yang, L., Yao, X., and Shao, J. (2013). The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079599"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/5\/720\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:50:43Z","timestamp":1760161843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/5\/720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["v13050720"],"URL":"https:\/\/doi.org\/10.3390\/v13050720","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]}}}